Hematology TimesCancer patients prefer computer-free interactionsNovember 3, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesFDA to rely on foreign authorities’ inspectionsNovember 1, 2017PharmacyRelated Issues
Hematology TimesFDA approves IV formulation of drug for CINVOctober 27, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Hematology TimesHigh symptom burden in advanced cancer patientsOctober 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesWomen may ask fewer questions at scientific conferencesOctober 18, 2017Related Issues
Hematology TimesCryotherapy can reduce signs of CIPNOctober 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesPrimary care may be inadequate for cancer survivorsOctober 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated Issues
Hematology TimesSome cancers linked to weight are on the rise in the USOctober 5, 2017Multiple MyelomaRelated Issues
Hematology TimesReport details progress, obstacles in cancer research and careSeptember 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated IssuesAMLALL
Hematology TimesR&D costs for cancer drugs may be lower than previously thoughtSeptember 13, 2017PharmacyRelated Issues
